KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.500 $0.720 Friday, 26th Apr 2024 ADXS stock ended at $0.555. This is 0.91% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 0.91% from a day low at $0.550 to a day high of $0.555.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Jan 14, 2021 $0.643 $0.665 $0.611 $0.636 10 889 813
Jan 13, 2021 $0.655 $0.724 $0.620 $0.681 21 525 756
Jan 12, 2021 $0.696 $0.740 $0.600 $0.649 27 062 558
Jan 11, 2021 $0.570 $0.698 $0.563 $0.662 34 010 228
Jan 08, 2021 $0.480 $0.560 $0.462 $0.540 20 810 707
Jan 07, 2021 $0.481 $0.481 $0.450 $0.461 8 308 496
Jan 06, 2021 $0.490 $0.515 $0.437 $0.448 13 643 178
Jan 05, 2021 $0.424 $0.575 $0.424 $0.530 39 962 513
Jan 04, 2021 $0.350 $0.430 $0.350 $0.417 12 050 411
Dec 31, 2020 $0.374 $0.379 $0.343 $0.349 8 741 682
Dec 30, 2020 $0.345 $0.409 $0.345 $0.383 11 090 687
Dec 29, 2020 $0.365 $0.370 $0.333 $0.345 5 233 542
Dec 28, 2020 $0.370 $0.388 $0.361 $0.363 5 675 979
Dec 24, 2020 $0.396 $0.404 $0.360 $0.385 7 816 145
Dec 23, 2020 $0.371 $0.450 $0.353 $0.406 38 576 937
Dec 22, 2020 $0.315 $0.335 $0.300 $0.313 8 750 142
Dec 21, 2020 $0.301 $0.324 $0.300 $0.309 4 116 388
Dec 18, 2020 $0.317 $0.318 $0.300 $0.300 3 737 281
Dec 17, 2020 $0.317 $0.325 $0.311 $0.313 2 446 511
Dec 16, 2020 $0.330 $0.330 $0.305 $0.314 5 691 754
Dec 15, 2020 $0.330 $0.332 $0.313 $0.330 3 564 493
Dec 14, 2020 $0.340 $0.349 $0.324 $0.327 4 116 330
Dec 11, 2020 $0.322 $0.350 $0.317 $0.332 6 329 892
Dec 10, 2020 $0.317 $0.333 $0.312 $0.321 5 426 666
Dec 09, 2020 $0.316 $0.319 $0.294 $0.315 6 693 481
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT